International Biotechnology Day: the invisible innovation driving advanced therapies

Behind every scientific breakthrough lies an essential yet often unseen element: the vector. In biotechnology, these invisible components play a crucial role in turning innovative ideas into life-changing therapies.

On the occasion of International Biotechnology Day, VIVEbiotech emphasizes the importance of lentiviral vectors in the development of advanced therapies, underscoring that innovation goes far beyond what is visible. Precision, scalability, and quality are key factors in making what once seemed impossible a reality.

Specialized in lentiviral vector manufacturing, VIVEbiotech focuses on driving scientific progress through high-quality solutions that enable both ex vivo and in vivo applications in gene and cell therapy. Its capabilities are built to adapt to each project’s needs, including a wide range of manufacturing scales, multiple pseudotypes and cell lines, integrating and non-integrating vectors, as well as diverse vector generations and transgene sizes.

With over ten years of experience in the field, the company has produced more than 200 bioreactor batches and contributed to global projects across the United States, Europe, Asia, and Australia. VIVEbiotech operates under rigorous regulatory standards, fully complying with FDA and EMA requirements.

These small yet powerful components have a massive impact on the advancement of new therapies, positioning them as a cornerstone of the future of medicine.

VIVEbiotech continues to partner with organizations worldwide to accelerate the development of advanced therapies, offering its expertise as a specialized lentiviral vector CDMO.